Wright Medical Group (WMGI) :The total money flow, which is calculated as the dollar value of composite uptick minus downtick trades was negative ($6.68 million) and the uptick to downtick ratio was 0.41. The transaction value on upticks was $4.55 million and on downticks, the transaction value was $11.23 million. In block trades, the transaction value of inflow done during uptick was $0.49 million. The transaction value of block trades during downticks was $7.81 million. The uptick to downtick block trade ratio was 0.06. The money flow was negative ($7.32 million), indicating the traders were booking profit on the price strength. Wright Medical Group (WMGI) rose $0.4 at $24.99, during intraday Wednesday , a rise of 1.63% over the previous days close.
Shares of Wright Medical Group N.V. rose by 5.13% in the last five trading days and 0.44% for the last 4 weeks. Wright Medical Group N.V. is up 51.45% in the last 3-month period. Year-to-Date the stock performance stands at 3.35%.
Wright Medical Group (WMGI) has an average broker rating of 1.38, which is interpreted as a Strong Buy, as rated by 16 equity analysts. Nonetheless, 12 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 2 other analysts advise a Buy. Nevertheless, the majority of 2 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.
Wright Medical Group (NASDAQ:WMGI): The stock opened at $24.6 and touched an intraday high of $25.035 on Wednesday. During the day, the stock corrected to an intraday low of $23.44, however, the bulls stepped in and pushed the price higher to close in the green at $24.99 with a gain of 1.63% for the day. The total traded volume for the day was 1,373,640. The stock had closed at $24.59 in the previous trading session.
Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Companys business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Companys products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.